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Metallothionein Synthesis and
Degradation: Relationship to Cadmium
Metabolism
by Robert J. Cousins*
Metallothionein is an integral component of the mechanism that regulates the metabolism ofcadmium
and zinc. The synthesis of this protein can be "induced" by oral or parenteral administration of either
metal. The metallothionein mRNA content ofliver polysomes is increased shortly after an influx ofsmall
amounts of either metal into hepatocytes. After sufficient amounts of this poly (A+) RNA have been
synthesized, there is a concomitant increase in metallothionein biosynthesis and metal binding. Unlike
synthesis, the degradation of metallothionein is markedly influenced by the species of metal bound. By
using in vivo and in vitro techniques, it has been possible to demonstrate that resistance of metallothio-
nein to degradation follows the order: thionein < zinc metallothionein < cadmium metallothionein.
Moreover, while the polypeptide chains ofcadmium metallothionein are degraded, it appears that liber-
ated cadmium ions are quickly incorporated into nascent chains ofthionein. The latter explains why the
cadmium content ofliver and kidney increases with age and environmental exposure. Since both zinc and
cadmium bind to metallothionein, it appears that the binding sites provided by this inducible species
provide a locus for interaction between zinc, a nutrient, and cadmium, an environmental contaminant.
Introduction
Cadmium and zinc are both group IIB elements,
therefore, it is understandable that the metabolism
of both is similar. Since research in the area of a
cadmium-zinc interaction has been well reviewed
(1), this review will be primarily limited to experi-
ments conducted in the author's laboratory.
In our initial experiments, we were interested in
studying the influence of dietary cadmium on vari-
ous biochemical parameters in swine (2). It was
clear that cadmium retention was closely related to
the dietary cadmium content. As had been noted by
others previously (1), we found that the liver and
kidney were the primary sites of dietary cadmium
deposition. Virtually no cadmium was found in
muscle, bone or blood.
Gel filtration chromatography of 40,000g super-
natants of kidney homogenates demonstrated that
the majority of the soluble, intracellular cadmium
was associated with a low molecular weight frac-
tion. Subsequent chromatographic steps allowed us
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to establish that this cadmium-binding fraction was
renal metallothionein (3). Its properties were similar
to equine and human metallothioneins isolated pre-
viously (4, 5). We also were able to detect a
cadmium-binding metallothionein in chicks fed 75
ppm cadmium (6).
It was clear from this early work that feeding
cadmium resulted in a concomitant increase in the
zinc content of liver and kidney. Most of this in-
crease in tissue zinc was accounted for as the solu-
ble, low molecular weight species, metallothionein.
These data were strongly suggestive of a link be-
tween cadmium and zinc metabolism that involves
metallothionein which acts as a common binding
ligand for both metals.
Metallothionein Synthesis
Metallothionein was not detected in appreciable
concentrations in animals not fed cadmium. There-
fore, a series ofexperiments was undertaken to es-
tablish ifthis protein was induced by cadmium. We
found that when cadmium containing 115mCd was
injected simultaneously with3H-cystine, substantial
amounts of radioactivity were incorporated into
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rats were injected with only tracer amounts ofcad-
mium, no "induction" ofmetallothionein occurred.
Moreover, when actinomycin D, an inhibitor of
mRNA synthesis, was administered prior to cad-
mium, the induction ofmetallothionein was not ob-
served. These data led us to propose that metal-
lothionein is indeed an induced protein. It was also
possible to show that a relatively small dose of
cadmium, which could induce metallothionein,
seemed to protect rats from an orally administered
acute dose ofthe metal (8). This observation was in
line with the concept that metallothionein is in some
way able to act as a sequestering agent which can
protect the body from the toxic effects ofcadmium
(1).
Since the body burden ofcadmium is usually ex-
tremely low, it is highly unlikely that metallothio-
nein exists for the sole purpose of sequestering
cadmium ions. With that rationale we set forth to
examine the role of metallothionein in mammalian
zinc metabolism. It was possible to demonstrate
that metallothionein could be induced by zinc just
as it could by administration of cadmium. Specifi-
cally zinc (65Zn) was incorporated with C14-cystine
during the induction of metallothionein in rat liver
(9). Intraperitoneal zinc administration resulted in
an increase in the serum zinc concentration for a
4-12 hr period. As zinc was cleared from the
plasma, it appeared to be taken up to a large extent
by the liver. Most of this increase in intracellular
hepatic zinc was accounted for in the cytosol frac-
tion as metallothionein-associated metal (10). The
increase in the hepatic zinc content and
metallothionein-associated zinc was inhibitable by
administration of actinomycin D prior to the zinc.
This suggests that RNA and protein synthesis are
required at some phase of the zinc accumulation
process in hepatocytes.
Zinc accumulation following an intraperitoneal
dose seemed to reach a maximum by 24 hr after
administration. Therefore, we conducted experi-
ments to investigate the rate ofhepatic metallothio-
nein synthesis for up to 24 hr after administration of
zinc. We found that the rate of synthesis, as mea-
sured by 35S-cystine incorporation, increased to a
maximum by 5 hr after zinc. This subsequently re-
turned to a basal level by 20 hr post-administration
(11). In contrast to the rate of35S-cystine incorpo-
ration, zinc incorporation into metallothionein was
only maximal by 20 hr after zinc administration.
This zinc stimulated increase in the rate of metal-
lothionein synthesis could be blocked by prior ad-
ministration of actinomycin D, cordycepin, or cy-
cloheximide. These results suggest that accumula-
tion of significant amounts ofzinc is directly corre-
lated with an increase in the rate ofmetallothionein
biosynthesis.
Inhibition of the synthesis of metallothionein by
two different inhibitors of transcription strongly
suggests that the induction of metallothionein oc-
curs via a mechanism that involves stimulation of
the transcription of metallothionein mRNA. In
order to gain more information about this
mechanism, we isolated rat liver polysomes and
translated their mRNA in a cell-free, polysomal
system (12). Polysomes from zinc-injected animals
synthesized more metallothionein-like polypeptides
than polysomes from control rats. In the next phase
of these experiments, it was possible to show that
the actual amount of metallothionein mRNA pres-
ent in polysomes, after zinc administration, follows
a time course that is nearly identical W*ith that seen
forthe rate ofmetallothionein synthesis in vivo (13).
For these latter experiments, poly(A+) mRNA was
isolated from rat liver polysomes by oligo-(dT) cel-
lulose chromatography. The poly(A)-containing
mRNA was translated in a wheat germ, cell-free
synthesizing system containing 3H-glycine, lysine,
and serine. The amount of newly translated 3H-
metallothionein could be quantitated either by gel
filtration or activated thiol-Sepharose chromatogra-
phy. The amount of polysomal metallothionein
mRNA was maximal 5 hr after administration of
zinc. This stimulation in metallothionein message
was inhibitable by prior administration of ac-
tinomycin D. The experiments cited above, as well
as experiments from other laboratories, fairly con-
clusively establish that liver metallothionein is an
induced protein. The induction process appears to
require an increase in the amount of intracellular
metal. In view of the important roles that zinc has
for maintenance ofcellular processes, as well as the
marked cytotoxic properties of cadmium, it is not
surprising that an intracellular ligand with strong
binding properties evolved.
Metallothionein Degradation
Hepatic metallothionein does not serve aterminal
storage function, since it is capable of undergoing
degradation. In an attempt to investigate this aspect
ofmetallothionein biochemistry, we induced a zinc
metallothionein, i.e. a metallothionein which con-
tained nearly exclusively zinc as the bound metal,
that was labeled with 65Zn and 35S-cysteine. The
degradation of this labeled protein was followed
after it reached its maximal level ofincorporation of
these labeled precursors, i.e., 24 hr after zinc ad-
ministration (14). We found that hepatic zinc
metallothionein was fairly rapidly degraded. The
half-life (t1) for Zn65 and S35 in the ti protein was 18
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suggests that the polypeptide chain is degraded
simultaneously with or shortly after removal of
bound zinc.
The degradative behavior of induced cadmium
metallothionein is markedly different from that ob-
served when zinc is the metal bound to the thionein
polypeptide chain. Hepatic cadmium metallothio-
nein was induced by cadmium and labeled with
115mCd and 3H-cystine. Maximal labeling was ob-
tained at 24 hr after cadmium administration. Theti
of3H in cadmium metallothionein was 3.5 days (15).
Of paramount importance, from the standpoint of
cadmium toxicity, was the observation in these
studies that cadmium (115mCd) did not appear to be
removed from the protein, at least during the 9 days
that degradation was monitored. These data suggest
that, in vivo, the binding affinity of cadmium to
metallothionein, relative to zinc, is sufficient to
allow for apreferential bindingofcadmium to newly
synthesized metallothionein polypeptides. This
would have the effect of maintaining the cadmium
content of metallothionein with concomitant con-
tinual degradation of the polypeptide chains.
In an effort to gain insight into the difference in
proteolytic susceptibility of zinc- and cadmium
metallothioneins, we conducted in vitro experi-
ments with both forms ofthe protein as well as with
thionein, the metal-free form of the protein (16).
Each form was degraded by incubation with trypsin
and pronase, while chymotrypsin had no influence
on the degradation of any form of the protein.
Lysosomal proteases were extremely active in de-
grading each form of the protein to the constituent
amino acids. Moreover, metal binding had a pro-
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FIGURE 1. Relationship of cadmium and zinc metallothionein
synthesis and degradation to hepatic accumulation ofinjected
cadmium and zinc.
nounced influence on the rate of proteolysis. At a
substrate to enzyme ratio of 300:1 35S-thionein was
more than 80%o degraded in about 1.5 hr, whereas
about 3 hr was required to degrade zinc metal-
lothionein to that extent. In contrast, cadmium
metallothionein was only 70% degraded after an in-
cubation period of 24 hr. These data show that dif-
ferences in susceptibility to proteolysis have a
marked influence on the metal bound to metal-
lothionein within cells. Since thionein is rapidly de-
graded, cellular concentrations of this species do
not accumulate. However, since cadmium metal-
lothionein is extremely resistant to degradation, its
concentration in cells is more likely to be main-
tained (Fig. 1).
Zinc Metabolism and
Homeostasis
Another phase of our work was designed to in-
vestigate the role of metallothionein in zinc metab-
olism. Using fluctuations in dietary zinc as a
method to alter zinc status, it became clear when
zinc status was elevated, the metallothionein con-
tent was increased in both liver and intestinal mu-
cosa (10, 17, 18). The intestinal zinc-binding protein
(19) has all ofthe characteristics necessary for clas-
sification as a metallothionein (4). The elevation of
zinc status was concomitant with a decrease in in-
testinal zinc absorption and sequestration of in-
tracellular mucosal cell zinc as metallothionein (10,
18, 19). Actinomycin D completely abolished the
ability ofanimals to make intestinal metallothionein
and to regulate intestinal zinc absorption, strongly
suggesting that the two processes are linked. It is
possible to show that during chronic cadmium tox-
icity, mucosal cell cadmium is associated with in-
testinal metallothionein (20). Cadmium has been
shown to replace zinc in metallothionein (4).
Therefore, it is likely that, in attempting to fulfill its
role in the homeostatic regulation of zinc metab-
olism, intestinal metallothionein is able to prevent
substantial amounts ofcadmium from traversing the
intestinal mucosal cells to the systemic circulation.
A scenario of events can be envisioned starting
with the absorption of zinc which illustrates how
metallothionein plays a role in the overall metab-
olism of this essential trace element. When zinc
enters the intestinal lumen, it is rapidly transported
across the mucosal cells to the basolateral mem-
brane for uptake into the plasma. This elevates the
plasma zinc concentration, which acts as a signal to
bring about the induction of hepatic and intestinal
metallothionein mRNA, which in turn is encoded
into metallothionein polypeptides. In the intestine,
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interact with zinc as it enters the mucosal cells from
the intestinal lumen. Since the binding of zinc to
metallothionein is probably greater than the trans-
port components necessary to remove zinc from the
intestinal mucosal cell to the circulation, the metal
remains bound to metallothionein. Presumably,
dietary cadmium is handled in a similar fashion. In
the liver, the nascent thionein polypeptide chains
appear to act as a ligand that is involved in the ac-
cumulation of zinc within hepatocytes.
Zinc and Cadmium Metabolism in
Isolated Hepatocytes
In a recently completed series of experiments
with rat liver parenchymal cells in primary culture,
we have been able to demonstrate that hepatic zinc
metabolism is an extremely dynamic process. When
hepatocytes are maintained in primary culture, the
zinc influx process occurs concomitantly with an
exchange process, thus there is little net accumula-
tion of intracellular zinc (21). However, if the zinc
concentration of the extracellular environment
(medium) is elevated, or ifglucocorticoids are pres-
ent in the medium, net accumulation occurs (22).
Accumulation is a temperature and energy depen-
dent saturable process. The extra zinc that is ac-
cumulated during these two situations is associated
with metallothionein, indicating the protein acts as a
ligand that is responsible for maintaining intracel-
lular zinc. The metabolism of cadmium in isolated
hepatocytes is nearly identical, except that the ac-
cumulation phase is very effective, because, unlike
zinc, cellular efflux of cadmium proceeds at a
slower rate (23).
Low Dietary Calcium and
Cadmium Metabolism
It is difficult to evaluate the metabolism of any
trace element without considering the overall nutri-
tional status of the individuals in question. As part
of our experiments on chronic cadmium toxicity,
we investigated the role ofthe dietary calcium level
on cadmium retention. It is well known that feeding
a low calcium diet will result in an acceleration of
calcium absorption by the intestinal mucosal cells
(24). We provided cadmium in the drinking water
for rats at 25 ppm. Those rats fed a low calcium diet
accumulated substantially more cadmium than
those fed a normal level ofcalcium (25, 26). A simi-
lar effect was noted earlier (27). During periods of
low dietary calcium, substantially more calcium-
binding protein (CaBP) is produced in the intestinal
mucosal cells. This protein is in some way involved
in the absorption ofdietary calcium (28). It has been
possible to show that during periods ofcalcium re-
striction, when the levels of this protein are par-
ticularly high, cadmium will also bind to the protein.
The enhanced cadmium binding activity of CaBP
may account for the increased accumulation of the
metal during periods oflow calcium status (25, 26).
A summary ofthe influence a low calcium diet has
on cadmium uptake is presented in Figure 2.
In this review, it is not possible to discuss all
aspects of cadmium toxicity. However, I should
mention the influence cadmium appears to have on
the activation of vitamin D to its hormonal form
(1,25-dihydroxycholecalciferol). In early experi-
ments we demonstrated that the renal conversion of
25-hydroxycholecalciferol, via the renal enzyme
25-hydroxycholecalciferol- l-hydroxylase was
markedly reduced in animals administered substan-
tial amounts ofcadmium (29). This observation has
been substantiated subsequently (30). Based upon
these observations, it is indeed likely that during
periods of chronic cadmium toxicity renal concen-
trations of cadmium develop that are sufficient to
alter the vitamin D hydroxylating capacity of the
kidney, which in turn will influence calcium metab-
olism.
Figure 3 is a schematic representation of how
various aspects of cadmium metabolism and tox-
icity may be related to metallothionein. As cad-
mium enters the intestinal mucosal cell, it probably
helps signal the induction of intestinal metallothio-
nein. This protein in turn sequesters a major portion
of the dietary cadmium that is taken up within the
mucosal cells. Cadmium that is transported via the
plasma is initially taken up by the liver cells and is
incorporated into hepatic metallothionein. We have
been able to show that hepatic cadmium-thionein is
able to undergo degradation, although at a slower
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calcium on enhanced cadmium accumulation.
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FIGURE 3. Proposed role of metallothionein in cadmium metab-
olism and toxicity.
rate than that found for either thionein or zinc
metallothionein. During this period, cadmium is
probably able to interact with other cellular compo-
nents. Eventually cadmium appears to be deposited
in kidney cells. Again most cadmium is bound to the
intracellular ligand, metallothionein. Since the kid-
ney cells appear to be able to synthesize metal-
lothionein, it is unlikely that cadmium is transported
from hepatocytes to kidney cells as metallothionein.
It is hoped that the experiments discussed in this
review point out that cadmium toxicity cannot be
considered as an isolated situation; rather it must be
integrated into all aspects of cell physiology and
trace element nutrition and metabolism.
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